We are live on ! Find out more
BA

Bard Associates Portfolio holdings

AUM $398M
1-Year Est. Return 54.32%
This Fund
S&P 500
This Quarter Est. Return
+0.1%
1 Year Est. Return
+54.32%
3 Year Est. Return
+200.06%
5 Year Est. Return
+225.83%
10 Year Est. Return
+1,331.15%
AUM
$208M
AUM Growth
-$6.31M
Cap. Flow
-$1.84M
Cap. Flow %
-0.88%
Top 10 Hldgs %
21.53%
Holding
183
New
5
Increased
14
Reduced
112
Closed
8

Top Buys

Rank Stock Value
1
XFLT
XAI Floating Rate & Alternative Income Trust
XFLT
+$2.03M
2
TEUM
Pareteum Corporation
TEUM
+$1.06M
3
SNOA icon
Sonoma Pharmaceuticals
SNOA
+$1.01M
4
BOXL icon
Boxlight
BOXL
+$944K
5
SACH
Sachem Capital Corp
SACH
+$859K

Top Sells

Rank Stock Value
1
EVI icon
EVI Industries
EVI
+$3.21M
2
SANW
S&W Seed Co
SANW
+$849K
3
CBMX
CombiMatrix Corporation
CBMX
+$610K
4
LMFA
LM Funding America
LMFA
+$303K
5
EPM icon
Evolution Petroleum
EPM
+$276K

Sector Composition

Rank Sector Weight
1 Real Estate 18.52%
2 Technology 13.7%
3 Industrials 12.73%
4 Materials 9.93%
5 Healthcare 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CETXW
151
DELISTED
Cemtrex Inc. Series 1 Warrant
CETXW
– –
0
– –
NBEV
152
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$148K 0.07%
68,000
– –
BBDC icon
153
Barings BDC
BBDC
$864M
$142K 0.07%
14,982
-1,525
-9% -$16.7K
EMKR
154
DELISTED
Emcore Corp
EMKR
$123K 0.06%
1,910
+80
+4% +$6K
ATCO
155
DELISTED
Atlas Corp.
ATCO
$117K 0.06%
17,294
-287
-2% -$1.87K
INUV icon
156
Inuvo
INUV
$15.1M
$115K 0.06%
14,200
-2,050
-13% -$17.7K
HROW icon
157
Harrow
HROW
$1.45B
$102K 0.05%
59,900
-800
-1% -$1.33K
MDLY
158
DELISTED
Medley Management Inc
MDLY
$98K 0.05%
1,500
– –
EYPT icon
159
EyePoint Inc
EYPT
$1.03B
$89K 0.04%
8,216
-230
-3% -$2.77K
RIBT
160
DELISTED
RiceBran Technologies
RIBT
$78K 0.04%
5,258
-180
-3% -$2.36K
AUY
161
DELISTED
Yamana Gold, Inc.
AUY
$75K 0.04%
23,957
-6,364
-21% -$17K
AYTU icon
162
AYTU BioPharma
AYTU
$23.9M
$71K 0.03%
+8
New +$95.5K
GTE icon
163
Gran Tierra Energy
GTE
$265M
$66K 0.03%
2,438
-175
-7% -$3.91K
SDPI
164
DELISTED
Superior Drilling Products Inc.
SDPI
$49K 0.02%
33,500
-4,000
-11% -$4.33K
SRTSW
165
DELISTED
Sensus Healthcare, Inc. Warrant expiring on 06/08/2020
SRTSW
– –
0
– –
LMFA
166
DELISTED
LM Funding America
LMFA
$40K 0.02%
3
-18
-86% -$303K
TIO
167
DELISTED
Tingo Group, Inc. Common Stock
TIO
$30K 0.01%
26,460
-111,340
-81% -$102K
TOVX icon
168
Theriva Biologics
TOVX
$9.64M
$29K 0.01%
6
-2
-25% -$12.5K
MBAI
169
Check-Cap
MBAI
$8.19M
$20K 0.01%
95
-19
-17% -$5.84K
QCLS
170
Q/C Technologies Inc
QCLS
$20.5M
– –
0
– –
DRIOW
171
DELISTED
DarioHealth Corp. Warrant
DRIOW
– –
0
– –
MICTW
172
DELISTED
Micronet Enertec Technologies, Inc. - Warrant
MICTW
$6K ﹤0.01%
39,520
– –
LMFAW
173
DELISTED
LM Funding America, Inc. Warrant
LMFAW
– –
0
– –
RIBTW
174
DELISTED
RiceBran Technologies - Warrant
RIBTW
$4K ﹤0.01%
40,200
– –
CHEKW
175
DELISTED
Check-Cap Ltd. Series A Warrant
CHEKW
– –
0
– –
4 5 6
7
8

Similar funds

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
NC
NovaPoint Capital Atlanta, Georgia $399M AUM 26.97% 1-Year Est. Return
T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $399M AUM 20.13% 1-Year Est. Return
THL
Tillman Hartley LLC Denver, Colorado $398M AUM 16.44% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return
IAA
Ironsides Asset Advisors Rocky Mount, North Carolina $399M AUM 13.99% 1-Year Est. Return
BWM
BCGM Wealth Management Lafayette, Indiana $398M AUM 17.85% 1-Year Est. Return
KHCM
Kettle Hill Capital Management New York $399M AUM 10.05% 1-Year Est. Return

Bard Associates's Q4 2017 Portfolio in Review

As of Q4 2017, Bard Associates held 183 positions worth $208M, down 2.9% from $215M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Bard Associates's Q4 2017 filing shows 5 new, 14 increased, 112 reduced and 8 closed positions. Its largest new stake was XAI Floating Rate & Alternative Income Trust: 39,620 shares worth $1.86M. The largest sale was EVI Industries, an estimated $3.21M.

By sector, the portfolio is most concentrated in Real Estate at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

  • Bard Associates's largest Q4 2017 buy was XAI Floating Rate & Alternative Income Trust: 39,620 shares worth $1.86M.
  • Bard Associates added most to Sonoma Pharmaceuticals in Q4 2017, an estimated $1.01M increase.
  • Bard Associates's biggest Q4 2017 reduction was EVI Industries, cutting an estimated $3.21M.
  • Bard Associates fully exited S&W Seed Co in Q4 2017, selling an estimated $849K.
  • Bard Associates's ten largest holdings make up 22% of its $208M portfolio in Q4 2017.
  • Bard Associates opened 5 new positions and closed 8 in Q4 2017.
  • Bard Associates's portfolio value fell 2.9% quarter-over-quarter to $208M.

Based on Bard Associates's 13F filing for Q4 2017, filed 13 Feb 2018.